The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Current Status of Platinum-Based Antitumor Drugs
Abstract
ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTCurrent Status of Platinum-Based Antitumor DrugsErnest Wong and Christen M. GiandomenicoView Author Information AnorMed Incorporated, 200-20353 64th Avenue, Langley, British Columbia, Canada V2Y 1N5 Cite this: Chem. Rev. 1999, 99, 9, 2451–2466Publication Date (Web):August 17, 1999Publication History Received22 February 1999Revised14 June 1999Published online17 August 1999Published inissue 8 September 1999https://pubs.acs.org/doi/10.1021/cr980420vhttps://doi.org/10.1021/cr980420vresearch-articleACS PublicationsCopyright © 1999 American Chemical SocietyRequest reuse permissionsArticle Views8091Altmetric-Citations1586LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Antineoplastic agents,Cancer,Ligands,Platinum,Toxicity Get e-Alerts
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Platinum Compounds: a New Class of Potent Antitumour Agents
ROSENBERG, B., VANCAMP, L., TROSKO, J. E., & MANSOUR, V. H. (1969) · Nature · doi:10.1038/222385a0 · Cited by 3,972
Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode
ROSENBERG, B., VAN CAMP, L., & KRIGAS, T. (1965) · Nature · doi:10.1038/205698a0 · Cited by 3,049
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
Jamieson, E. R., & Lippard, S. J. (1999) · Chemical Reviews · doi:10.1021/cr980421n · Cited by 2,949
Carboplatin dosage: prospective evaluation of a simple formula based on renal function.
Calvert, A. H., Newell, D. R., Gumbrell, L. A., O'Reilly, S., Burnell, M., Boxall, F. E., Siddik, Z. H., Judson, I. R., Gore, M. E., & Wiltshaw, E. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.11.1748 · Cited by 1,866
Why Does Cisplatin Reach Guanine-N7 with Competing S-Donor Ligands Available in the Cell?
Reedijk, J. (1999) · Chemical Reviews · doi:10.1021/cr980422f · Cited by 771
Lebwohl, D., & Canetta, R. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00224-x · Cited by 754
The role of DNA mismatch repair in platinum drug resistance.
Fink, D. A., Nebel, S., Aebi, S. P., Zheng, H., Cenni, B., Nehmé, A., Christen, R. D., & Howell, S. B. (1996) · PubMed · Cited by 597
Improved understanding in platinium antitumour chemistry
Reedijk, J. (1996) · Chemical Communications · doi:10.1039/cc9960000801 · Cited by 589
Oxaliplatin: mechanism of action and antineoplastic activity.
Raymond, É., Faivre, S. J., WOYNAROWSKI, J. M., & Chaney, S. G. (1998) · PubMed · Cited by 520
Behrens, B. C., Hamilton, T. C., Masuda, H., Grotzinger, K. R., Whang‐Peng, J., Louie, K. G., Knutsen, T., McKoy, W. M., Young, R. C., & Ozols, R. F. (1987) · PubMed · Cited by 498
Rosenberg, B., Van Camp, L., Grimley, E. B., & Thomson, A. J. (1967) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)96186-7 · Cited by 420
Cubeddu, L. X., Hoffmann, I. S., Fuenmayor, N. T., & Finn, A. L. (1990) · New England Journal of Medicine · doi:10.1056/nejm199003223221204 · Cited by 407
Marty, M., Pouillart, P., Scholl, S., Droz, J. P., Azab, M., Brion, N., Pujade-Lauraine, E., Paule, B., Paes, D., & Bons, J. (1990) · New England Journal of Medicine · doi:10.1056/nejm199003223221205 · Cited by 406
New Cisplatin Analogues in Development: A Review
Weiss, R. B., & Christian, M. C. (1993) · Drugs · doi:10.2165/00003495-199346030-00003 · Cited by 404
The successful regression of large solid sarcoma 180 tumors by platinum compounds.
Rosenberg, B., & Vancamp, L. (1970) · PubMed · Cited by 376
The influence of structure on the activity and toxicity of Pt anti-cancer drugs
Hambley, T. W. (1997) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(97)00023-4 · Cited by 348
Oral chemotherapy: rationale and future directions.
DeMario, M. D., & Ratain, M. J. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.7.2557 · Cited by 293
Bellon, S. F., Coleman, J. H., & Lippard, S. J. (1991) · Biochemistry · doi:10.1021/bi00246a021 · Cited by 291
The mechanism of action of platinum antitumor drugs
Reedijk, J. (1987) · Pure and Applied Chemistry · doi:10.1351/pac198759020181 · Cited by 277
Reduction and Anticancer Activity of Platinum(IV) Complexes
Choi, S., Filotto, C., Bisanzo, M., Delaney, S., Lagasee, D., Whitworth, J. L., Jusko, A., Li, C., Wood, N. A., Willingham, J., et al. (1998) · Inorganic Chemistry · doi:10.1021/ic971047x · Cited by 270
Mistry, P., Kelland, L., Abel, G., Sidhar, S., & Harrap, K. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.279 · Cited by 261
Giandomenico, C. M., Abrams, M. J., Murrer, B. A., Vollano, J. F., Rheinheimer, M. I., Wyer, S. B., Bossard, G. E., & Higgins, J. D. (1995) · Inorganic Chemistry · doi:10.1021/ic00109a004 · Cited by 248
Self-citationBrabec, V, & Leng, M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.5345 · Cited by 240
New platinum antitumor complexes
Kelland, L. R. (1993) · Critical Reviews in Oncology/Hematology · doi:10.1016/1040-8428(93)90042-3 · Cited by 237
Richon, V. M., Schulte, N. A., & Eastman, A. R. (1987) · PubMed · Cited by 229
Kèlland, L. R., Abel, G., McKeage, M. J., Jones, M., Goddard, P. M., Valenti, M., Murrer, B. A., & Harrap, K. R. (1993) · PubMed · Cited by 224
Pinto, A. L., & Lippard, S. J. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.14.4616 · Cited by 219
Platinum-Induced Filamentous Growth in Escherichia coli
Rosenberg, B., Renshaw, E., Vancamp, L., Hartwick, J., & Drobnik, J. (1967) · Journal of Bacteriology · doi:10.1128/jb.93.2.716-721.1967 · Cited by 212
Smith, D. B., Newlands, E., Rustin, G. J. S., et al. (1991) · The Lancet · doi:10.1016/0140-6736(91)90555-4 · Cited by 210
Versantvoort, C., Broxterman, H., Bagrij, T., Scheper, R., & Twentyman, P. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.281 · Cited by 207
Ciccarelli, R. B., Solomon, M. J., Varshavsky, A., & Lippard, S. J. (1985) · Biochemistry · doi:10.1021/bi00347a005 · Cited by 205
Some Biological Effects of Platinum Compounds: New Agents for the Control of Tumours
Rosenberg, B. (1971) · Platinum Metals Review · doi:10.1595/003214071x1524251 · Cited by 203
Zhen, W., Link, C. J., O'Connor, P. M., Reed, E., Parker, R., Howell, S. B., & Bohr, V. A. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.9.3689 · Cited by 196
Holford, J., Sharp, S., Murrer, B., Abrams, M., & Kelland, L. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.59 · Cited by 196
Hills, C., Kelland, L., Abel, G., Siracky, J., Wilson, A., & Harrap, K. (1989) · British Journal of Cancer · doi:10.1038/bjc.1989.108 · Cited by 183
Loh, S., Mistry, P., Kelland, L., Abel, G., & Harrap, K. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.419 · Cited by 167
Effect of Glutathione on DNA Repair in Cisplatin-Resistant Human Ovarian Cancer Cell Lines
Lai, G.-M., Ozols, R. F., Young, R. C., & Hamilton, T. C. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.7.535 · Cited by 167
Metal Antitumor Compounds: The Mechanism of Action of Platinum Complexes
Johnson, N. P., Butour, J.-L., Villani, G., Wimmer, F. L., Defais, M., Pierson, V., & Brabec, V. (1989) · Progress in Clinical Biochemistry and Medicine · doi:10.1007/978-3-642-74760-1_1 · Cited by 158
Eastman, A. R., & Barry, M. A. (1987) · Biochemistry · doi:10.1021/bi00386a009 · Cited by 152
Bellon, S. F., & Lippard, S. J. (1990) · Biophysical Chemistry · doi:10.1016/0301-4622(90)80007-t · Cited by 148
Metal complexes in medicine: Design and mechanism of action
Sadler, P. J., & Guo, Z. (1998) · Pure and Applied Chemistry · doi:10.1351/pac199870040863 · Cited by 138
Hospers, G. A. P. (1989) · Lung Cancer · doi:10.1016/0169-5002(89)90120-7 · Cited by 129
A novel trans-platinum coordination complex possessing in vitro and in vivo antitumor activity.
Kèlland, L. R., BARNARD, C. F. J., Mellish, K. J., Jones, M. A., Goddard, P. M., Valenti, M. R., Bryant, A., Murrer, B. A., & Harrap, K. R. (1994) · PubMed · Cited by 128
Farrell, N. (1996) · PubMed · Cited by 119
Mellish, K. J., Kèlland, L. R., & Harrap, K. R. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.322 · Cited by 115
Farrell, N. P. (1993) · Cancer Investigation · doi:10.3109/07357909309011676 · Cited by 113
Farrell, N. P., Appleton, T. G., Qu, Y., Roberts, J. D., Fontes, A. P. S., Skov, K. A., Wu, P., & Zou, Y. (1995) · Biochemistry · doi:10.1021/bi00047a013 · Cited by 108
Ongoing and unsaid on oxaliplatin: the hope
Cvitkovic, E. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.429 · Cited by 104
Misset, J. L. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.428 · Cited by 103
Shi, T., Berglund, J., & Elding, L. I. (1996) · Inorganic Chemistry · doi:10.1021/ic951598s · Cited by 103
Glutathione-mediated activation of anticancer platinum(IV) complexes
Eastman, A. R. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90581-8 · Cited by 101
Inorganic Chemistry in Biology and Medicine
Martell, A. E. (1980) · ACS symposium series · doi:10.1021/bk-1980-0140 · Cited by 96
Hosking, L. K., Whelan, R. D. H., Shellard, S. A., Bedford, P., & Hill, B. T. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90364-q · Cited by 93
Teicher, B. A., Holden, S. A., Herman, T. S., Sotomayor, E. A., Khandekar, V. S., Rosbe, K. W., Brann, T. W., Korbut, T. T., & Frei, E. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910470214 · Cited by 87
Bierbach, U., Hambley, T. W., & Farrell, N. P. (1998) · Inorganic Chemistry · doi:10.1021/ic970420y · Cited by 77
Murray, V., Motyka, H., England, P. R., Wickham, G., Lee, H. H., Denny, W. A., & McFadyen, W. D. (1992) · Biochemistry · doi:10.1021/bi00162a020 · Cited by 64
Perez, R. P., O'Dwyer, P. J., Handel, L. M., Ozols, R. F., & Hamilton, T. C. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910480219 · Cited by 48
Intracellular glutathione and cytotoxicity of platinum complexes
Pendyala, L., Creaven, P. J., Perez, R. P., Zdanowicz, J., & Raghavan, D. (1995) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00689042 · Cited by 45
Ladner, C., Ehninger, G., GEY, K. F., & Clemens, M. (1989) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00689585 · Cited by 40
Jennerwein, M. M., Eastman, A. R., & Khokhar, A. R. (1991) · Mutation Research/DNA Repair · doi:10.1016/0921-8777(91)90044-p · Cited by 27
Jones, M. A., Siracký, J., Kèlland, L. R., & Harrap, K. R. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.5 · Cited by 26
Secondary screening of platinum compounds in human ovarian cancer xenografts in nude mice
Boven, E., Nauta, M. M., Schlüper, H. M. M., Elferink, F., van der Vijgh, W. J. F., & Pinedo, H. M. (1985) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(85)90023-9 · Cited by 22
Synthesis and in vitro biological evaluation of new triphenylethylene platinum (II) complexes
He, Y., Groleau, S., -Gaudreault, R., Caron, M., Thérien, H.-M., & Bérubé, G. (1995) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(95)00381-3 · Cited by 22
Han, I., Ling, Y. H., Al-Baker, S., Khokhar, A. R., & Perez-Soler, R. (1993) · PubMed · Cited by 19
Oxaliplatin for the treatment of advanced colorectal cancer: future directions.
Ducreux, M. P., Louvet, C., Bekradda, M., et al. (1998) · PubMed · Cited by 18
Cited by
Cellular processing of platinum anticancer drugs
Wang, D., & Lippard, S. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1691 · Cited by 3,801
Cisplatin: The first metal based anticancer drug
Ghosh, S. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.102925 · Cited by 1,751
Direct Cellular Responses to Platinum-Induced DNA Damage
Jung, Y., & Lippard, S. J. (2007) · Chemical Reviews · doi:10.1021/cr068207j · Cited by 1,391
Block copolymer micelles in nanomedicine applications
Cabral, H., Miyata, K., Osada, K., & Kataoka, K. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00199 · Cited by 1,309
Platinum-based drugs for cancer therapy and anti-tumor strategies
Zhang, C., Xu, C., Gao, X., & Yao, Q. (2022) · Theranostics · doi:10.7150/thno.69424 · Cited by 1,018
Metadata
- Authors
- Wong, E., & Giandomenico, C. M.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 1999-08-17
- Volume
- 99
- Issue
- 9
- Pages
- 2451-2466
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2048168597
- Cited by
- 1,800
- References
- 65
- FWCI
- 2.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.